138 related articles for article (PubMed ID: 11350491)
1. Cytotoxic T-cell lymphoma presenting as secondary myelofibrosis with high levels of PDGF and TGF-beta.
Abe Y; Ohshima K; Shiratsuchi M; Honda K; Nishimura J; Nawata H; Muta K
Eur J Haematol; 2001 Mar; 66(3):210-2. PubMed ID: 11350491
[No Abstract] [Full Text] [Related]
2. Peripheral T cell lymphoma, not otherwise specified with myelofibrosis: report of a case with review of the literature.
Sekiguchi Y; Shirane S; Shimada A; Ichikawa K; Wakabayashi M; Sugimoto K; Tomita S; Izumi H; Nakamura N; Sawada T; Ohta Y; Komatsu N; Noguchi M
Int J Clin Exp Pathol; 2015; 8(4):4186-203. PubMed ID: 26097612
[TBL] [Abstract][Full Text] [Related]
3. Peripheral T-cell lymphoma presenting with rapidly progressing myelofibrosis.
Uehara E; Tasaka T; Matsuhashi Y; Fujita M; Tamura T; Shimoura Y; Mano S; Kuwajima M; Nagai M
Leuk Lymphoma; 2003 Feb; 44(2):361-3. PubMed ID: 12688359
[TBL] [Abstract][Full Text] [Related]
4. A new prognostic score comprising lactate dehydrogenase, albumin and neutrophil to lymphocyte ratio to predict sensitivity to first-line chemotherapy in patients with peripheral T-cell lymphomas.
Kaito S; Kanemasa Y; Sasaki Y; Okuya T; Yamaguchi T; Funasaka C; Shimoyama T; Omuro Y; Hishima T; Maeda Y
Int J Hematol; 2018 Apr; 107(4):451-459. PubMed ID: 29103138
[TBL] [Abstract][Full Text] [Related]
5. [Primary malignant non-Hodgkin lymphoma of the larynx: report of a case].
Elmazghi A; Elkacemi H; Lalya I; Zaidi H; Harmouch A; Kanouni L; Kebdani T; Hassouni K; Benjaafar N; Elgueddari B
Pan Afr Med J; 2011; 9():17. PubMed ID: 22355427
[TBL] [Abstract][Full Text] [Related]
6. Atypical presentation of a central nervous system aspergillosis in a peripheral T cell lymphoma patient.
Larroquette M; Issa N; Gabriel F; Camou F
Ann Hematol; 2020 Nov; 99(11):2711-2713. PubMed ID: 32681445
[No Abstract] [Full Text] [Related]
7. Durable clinical remission induced by romidepsin for chemotherapy-refractory peripheral T-cell lymphoma with central nervous system involvement.
Chan KL; van der Weyden C; Khoo C; Lade S; Blombery P; Westerman D; Khot A; Melo B; Johnstone RW; Prince HM; Dickinson M
Leuk Lymphoma; 2017 Apr; 58(4):996-998. PubMed ID: 27558082
[No Abstract] [Full Text] [Related]
8. An unusual extranodal T-cell non-Hodgkin lymphoma.
Coats JT; Mackie ADR; Kernohan NM; Ramkumar PG; McMahon LM; Goodlad JR; Tauro S
Lancet; 2016 Sep; 388(10049):1127-1128. PubMed ID: 27628520
[No Abstract] [Full Text] [Related]
9. Cytotoxic Molecule-positive Epstein-Barr Virus-associated Peripheral T-cell Lymphoma in a 20-Month-old Child: A Case Report and Review of the Literature.
Zhang H; Kheradpour A; Rowsell EH; Zuppan CW; Weiss LM; Wang J
J Pediatr Hematol Oncol; 2015 Nov; 37(8):e475-80. PubMed ID: 26056791
[TBL] [Abstract][Full Text] [Related]
10. Primary breast peripheral T-cell lymphoma not otherwise specified: report of a case.
Muroya D; Toh U; Iwakuma N; Nakagawa S; Mishima M; Takahashi R; Takenaka M; Shirouzu K; Agaki Y
Surg Today; 2015 Jan; 45(1):115-20. PubMed ID: 24395027
[TBL] [Abstract][Full Text] [Related]
11. [Experience in treating peripheral T-cell lymphomas by a new program].
Butenko AK
Lik Sprava; 1996; (7-9):160-2. PubMed ID: 9072239
[TBL] [Abstract][Full Text] [Related]
12. [Diagnosis and treatment of peripheral T-cell lymphoma].
Suzumiya J; Moriyama I; Kawakami K
Nihon Rinsho; 2012 Apr; 70 Suppl 2():519-24. PubMed ID: 23134009
[No Abstract] [Full Text] [Related]
13. Diffuse large B-cell lymphoma in patient after treatment of angioimmunoblastic T-cell lymphoma.
Skugor ND; Perić Z; Vrhovac R; Radić-Kristo D; Kardum-Skelin I; Jaksić B
Coll Antropol; 2010 Mar; 34(1):241-5. PubMed ID: 20432757
[TBL] [Abstract][Full Text] [Related]
14. Autologous stem cell transplantation as frontline strategy for peripheral T-cell lymphoma: A single-centre experience.
Han X; Zhang W; Zhou D; Ruan J; Duan M; Zhu T; Li J; Cai H; Cao X; Ouyang M
J Int Med Res; 2017 Feb; 45(1):290-302. PubMed ID: 28222648
[TBL] [Abstract][Full Text] [Related]
15. A rare case report of 8p11 myeloid and lymphoid neoplasm with FGFR1 abnormality in a young adult.
Shaaban H; Dabu J; Al-Rabi K; Gauchan D; Guron G
Ann Hematol; 2013 Jan; 92(2):285-6. PubMed ID: 22941307
[No Abstract] [Full Text] [Related]
16. Angioimmunoblastic T-cell lymphoma with intramedullary production of platelet-derived growth factor and possibly complicating myelofibrosis: report of a case with review of the literature.
Sekiguchi Y; Matsuzawa N; Shimada A; Imai H; Wakabayashi M; Sugimoto K; Nakamura N; Sawada T; Izutsu K; Takeuchi K; Ohta Y; Komatsu N; Noguchi M
Int J Hematol; 2013 Aug; 98(2):250-7. PubMed ID: 23846384
[TBL] [Abstract][Full Text] [Related]
17. Successful treatment of angioimmunoblastic lymphadenopathy with dysproteinemia-type T-cell lymphoma by combined methotrexate and prednisone.
Gerlando Q; Barbera V; Ammatuna E; Franco V; Florena AM; Mariani G
Haematologica; 2000 Aug; 85(8):880-1. PubMed ID: 10942945
[No Abstract] [Full Text] [Related]
18. Strategies for relapsed peripheral T-cell lymphoma: the tail that wags the curve.
Lunning MA; Moskowitz AJ; Horwitz S
J Clin Oncol; 2013 Jun; 31(16):1922-7. PubMed ID: 23630204
[TBL] [Abstract][Full Text] [Related]
19. The derived neutrophil-to-lymphocyte ratio is an independent prognostic factor in patients with angioimmunoblastic T-cell lymphoma.
Hong H; Fang X; Huang H; Wang Z; Lin T; Yao H
Br J Haematol; 2020 Jun; 189(5):908-912. PubMed ID: 32103494
[TBL] [Abstract][Full Text] [Related]
20. [Follicular lymphoma complicated with myelofibrosis and macroglobulinemia at initial presentation].
Kuroda H; Abe T; Jomen W; Yoshida M; Matsuno T; Sato M; Yamada M; Sakurai T; Fujii S; Maeda M; Fujita M; Nagashima K; Murase K; Kato J
Rinsho Ketsueki; 2013 Nov; 54(11):2068-73. PubMed ID: 24305541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
